skip to main content
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Refinado por: idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia
Material Type:
Artigo
Adicionar ao Meu Espaço

Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia

SHAH, Neil P ; KANTARJIAN, Hagop M ; KHOROSHKO, Nina ; PAQUETTE, Ronald L ; DEININGER, Michael ; COLLINS, Robert H ; OTERO, Irma ; HUGHES, Timothy ; BLEICKARDT, Eric ; STRAUSS, Lewis ; FRANCIS, Stephen ; HOCHHAUS, Andreas ; KIM, Dong-Wook ; REA, Delphine ; DORLHIAC-LLACER, Pedro E ; MILONE, Jorge H ; VELA-OJEDA, Jorge ; SILVER, Richard T ; KHOURY, H. Jean ; CHARBONNIER, Aude

Journal of clinical oncology, 2008-07, Vol.26 (19), p.3204-3212 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Texto completo disponível

Buscando em bases de dados remotas. Favor aguardar.